21. November 2009 01:57
Toxic dust: Toxins in coal-tar-based sealcoats in parking lots may be the culprit in contaminated house dust, according to a USGS study. PAHs - or polycyclic aromatic hydrocarbons - are large molecules found in oil, coal and tar deposits, and can have toxic effects.
[More]
18. November 2009 07:38
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today announced new pre-clinical data from its ALN-VSP program presented at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics International conference being held November 15 - 19, 2009 in Boston, Mass.
[More]
2e16dd3c-6f4f-44b3-9889-330f4bb7656d|0|.0
Posted in: Drug Trial News | Pharmaceutical News
Tags: Blood Vessel, Cancer, Cell, Cell Proliferation, Hepatocellular Carcinoma, Hypercholesterolemia, microRNA, Nanoparticle, Oncology, Physiology, RNAi Therapeutics, siRNA, VEGF, Virus
17. November 2009 02:02
Titanium dioxide (TiO2) nanoparticles, found in everything from cosmetics to sunscreen to paint to vitamins, caused systemic genetic damage in mice, according to a comprehensive study conducted by researchers at UCLA's Jonsson Comprehensive Cancer Center.
[More]
13. November 2009 00:27
BioAlliance Pharma SA, a company dedicated to the treatment and supportive care of cancer and AIDS patients, has presented its results on new oral chemotherapy nanoparticle formulation at the AAPS (American Association of Pharmaceutical Scientists) Annual Meeting in Los Angeles (November 8 to 12, 2009).
[More]
5. November 2009 23:20
Abraxis BioScience, Inc., a fully integrated biotechnology company, today reported unaudited financial results for the third quarter ending September 30, 2009.
[More]
e2e66afc-1a09-40ac-b5e8-cf8599dc974d|0|.0
Posted in: Business / Finance
Tags: Abraxane, Anthracycline, Biotechnology, Breast Cancer, Cancer, Cell, Chemotherapy, Investment, Lung Cancer, Melanoma, Nanoparticle, Non-Small Cell Lung Cancer, Oncology, Paclitaxel, Pancreatic Cancer, Small Cell Lung Cancer
5. November 2009 16:31
Scientists have shown in the laboratory that metal nanoparticles damaged the DNA in cells on the other side of a cellular barrier. The nanoparticles did not cause the damage by passing through the barrier, but generated signalling molecules within the barrier cells that were then transmitted to cause damage in cells the other side of the barrier.
[More]
5. November 2009 08:38
Abraxis BioScience, Inc., a fully integrated biotechnology company, today announced that the Office of Orphan Products Development of the Food and Drug Administration (FDA) has granted orphan drug designation to the chemotherapy agent ABRAXANE® for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) for the treatment of pancreatic cancer as well as stage IIB-IV melanoma.
[More]
123516b3-a08b-479f-8092-ca49c7893b49|0|.0
Posted in: Medical Condition News | Pharmaceutical News
Tags: Abraxane, Anthracycline, Biotechnology, Breast Cancer, Cancer, Cell, Chemotherapy, Dacarbazine, Gemcitabine, Melanoma, Nanoparticle, Paclitaxel, Pancreatic Cancer, Skin Cancer
5. November 2009 07:41
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it presented new data related to its overall delivery research efforts including the rational design of Mimetic Lipoprotein Particles, or MLPs, a novel technology for the systemic delivery of small interfering RNAs, or siRNAs, the molecules that mediate RNAi.
[More]
731d501d-753a-4b06-a250-b0868714e3b3|0|.0
Posted in: Business / Finance | Medical Science News
Tags: Antisense, Biochemistry, Cell, Cholesterol, Gene Expression, Hepatocellular Carcinoma, Herpes, Herpes Simplex, Herpes Simplex Virus-2, Hypercholesterolemia, Lipoprotein, Metabolism, Microbicide, microRNA, Nanoparticle, Oncology, Pediatrics, Pharmacology, Physiology, RNAi Therapeutics, siRNA, VEGF, Virus
5. November 2009 02:36
Abraxis Health, a fully-integrated personalized healthcare division of Abraxis BioScience, Inc., today announced the dedication of its new manufacturing facility in Phoenix, Arizona. The state of the art biopharma manufacturing plant represents a $70 million investment by LA-based Abraxis, and will create up to 200 high tech jobs.
[More]
2. November 2009 00:08
Going smaller could bring better results, especially when it comes to cancer-fighting drugs.
[More]
14. October 2009 05:57
Searching for biomarkers that can warn of diseases such as cancer while they are still in their earliest stage is likely to become far easier thanks to an innovative biosensor chip developed by Stanford University researchers.
[More]
9ecc8360-1447-4e28-b252-c400e48775b5|0|.0
Posted in: Device / Technology News | Medical Science News | Medical Condition News
Tags: Antibody, Biomarker, Biosensor, Cancer, Cell, Chemotherapy, Magnetic Nanoparticle, Nanoparticle, Nanotechnology, Obstetrics, Radiology, Urology, Veterans Affairs
12. October 2009 04:17
Eric Boerwinkle, Ph.D., a professor at The University of Texas Health Science Center at Houston, has received a $26 million federal stimulus grant to lead an effort to pinpoint genetic factors affecting the risk of heart, lung and blood diseases.
[More]
f9f3756d-341a-458e-ad65-c8f33d904424|0|.0
Posted in: Medical Science News
Tags: Anti-Inflammatory, Arthritis, Aspirin, Atherosclerosis, Biochemistry, Brain, Cancer, DNA, Genetics, Gout, Ibuprofen, Lymphoma, Nanoparticle, Neuroscience, Pharmacology, Stroke
9. October 2009 04:48
Clemson bioengineer Frank Alexis is designing new ways to target drugs and reduce the chances for side effects.
[More]
8. October 2009 04:40
Officials of Kylin Therapeutics Inc., a leading RNAi company, announced that they have received a notice of allowance from the U.S. Patent and Trademark Office for its first U.S. patent application.
[More]
7. October 2009 05:57
Theresa M. Reineke, associate professor of chemistry in the College of Science, and colleagues in her lab at Virginia Tech and at the University of Cincinnati have developed a new molecule that can travel into cells, deliver genetic cargo, and packs a beacon so scientists can follow its movements in living systems.
[More] 
Subscribe